HilleVax Inc Sustainability Reports
HilleVax, Inc. is a biopharmaceutical company focused on the development and commercialization of novel vaccine candidates. Its programs have focused primarily on virus-like particle based vaccine candidates for the prevention of acute gastroenteritis caused by norovirus infection.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
1 reports from 2022 to 2022
Company Profile
HilleVax, Inc. is a biopharmaceutical company focused on the development and commercialization of novel vaccine candidates. Its programs have focused primarily on virus-like particle based vaccine candidates for the prevention of acute gastroenteritis caused by norovirus infection.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
